Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Biovinc, Llc in January, 2020 for $999,300.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI125060-02 | Phase II | 999,300 | January 13, 2020 | |||||||
A SBIR Phase I contract was awarded to Biovinc, Llc in July, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AR073727-01 | Phase I | 225,000 | July 1, 2018 | |||||||
A STTR Phase I contract was awarded to Biovinc, Llc in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41CA235996-01A1 | Phase I | 225,000 | September 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Biovinc, Llc in July, 2016 for $180,807.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI125060-01 | Phase I | 180,807 | July 1, 2016 | |||||||
A STTR Phase I contract was awarded to Biovinc, Llc in January, 2016 for $149,963.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41DE025789-01 | Phase I | 149,963 | January 8, 2016 | |||||||
A STTR Phase II contract was awarded to Biovinc, Llc in September, 2017 for $1,500,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42DE025789-02 | Phase II | 1,500,000 | September 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Biovinc, Llc in May, 2015 for $224,997.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR067021-01A1 | Phase I | 224,997 | May 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Biovinc, Llc in August, 2015 for $150,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DE025524-01 | Phase I | 150,000 | August 21, 2015 | |||||||
A SBIR Phase II contract was awarded to Biovinc, Llc in March, 2017 for $2,181,764.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DE025524-02 | Phase II | 2,181,764 | March 15, 2017 | |||||||
A SBIR Phase I contract was awarded to Biovinc, Llc in March, 2023 for $296,779.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI175069-01 | Phase I | 296,779 | March 3, 2023 |